2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical genetics<br />
birth defects is similar to developmental anomalies that are observed in<br />
an animal model with vitamin A or retinoic acid deficiency. We describe<br />
an infant with hypoplastic left heart, right pulmonary artery and lung hypoplasia,<br />
eventration <strong>of</strong> right hemidiaphragm, complete hypospadias<br />
and absent gonads . The karyotype was normal (46,XY) and FISH for<br />
SRY locus was present . Endocrine evaluations were suggestive <strong>of</strong> primary<br />
hypogonadism . Low testosterone, AMH (anti mullerian hormone)<br />
and Inhibin B values along with absence <strong>of</strong> visualized testicular tissue<br />
and Mullerian structures by imaging studies, indicated a defect in early<br />
embryogenesis . Interestingly, the level <strong>of</strong> plasma free retinol was low,<br />
consistent with severe vitamin A deficiency, supporting the hypothesis<br />
that a defect in vitamin A metabolism may have an etiological role in<br />
this syndrome with multiple congenital anomalies .<br />
P01.343<br />
Perrault syndrome: Report <strong>of</strong> Four New cases, Review and<br />
Exclusion <strong>of</strong> candidate Genes<br />
S. Marlin 1,2 , D. Lacombe 3 , L. Jonard 4 , N. Leboulanger 4 , D. Bonneau 5 , C.<br />
Goiset 3 , T. Billette de Villemeur 4 , S. Cabrol 4 , M. Houang 4 , D. Feldmann 4 , F.<br />
Denoyelle 4 ;<br />
1 Hôpital Armand Trousseau, paris, France, 2 INSERM U587, Centre de référence<br />
des surdités génétiques, Paris, France, 3 Hôpital Pellegrin, Bordeaux,<br />
France, 4 Hôpital Armand Trousseau, Paris, France, 5 CHU, Angers, France.<br />
Sensorineural hearing impairment and ovarian dysgenesis are the<br />
main clinical signs <strong>of</strong> the Perrault syndrome. This syndrome was first<br />
described by Perrault et al in 1951. Since this first report, about 30<br />
cases were described . More recently, some authors have reported<br />
neurologic abnormalities in Perrault syndrome, in particular progressive<br />
cerebellar ataxia and mental retardation . We present here on<br />
three sporadic and two familial new cases <strong>of</strong> Perrault syndrome . Only<br />
two <strong>of</strong> them present with neurological defect . We analyse the clinical<br />
features <strong>of</strong> this five patients and review the published cases in order<br />
to evaluate the frequency <strong>of</strong> the neurological defect in this syndrome .<br />
Moreover, we exclude GBG2, POLG and FOXL2 as candidate genes<br />
in Perrault syndrome .<br />
P01.344<br />
susceptibility markers for PFAPA disease<br />
R. Gershoni-Baruch 1,2 , E. Dagan 1,3 , K. Ihab 4 , A. Mori 1 , N. Amar 1 , R. Brik 4,2 ;<br />
1 Rambam Health Care Campus, Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Haifa, Israel,<br />
2 The Ruth and Bruce Rappaport Faculty <strong>of</strong> Medicine, Technion-Institute <strong>of</strong><br />
Technology, Haifa, Israel, 3 Department <strong>of</strong> Nursing, University <strong>of</strong> Haifa, Haifa,<br />
Israel, 4 Rambam Health Care Campus, Department <strong>of</strong> Pediatrics, Haifa, Israel.<br />
Periodic fever syndrome (PFAPA) is characterized by aphthous stomatitis,<br />
pharyngitis and cervical adenitis . The periodic fever and autoinflammatory<br />
syndromes constitute a group <strong>of</strong> diseases characterized<br />
by repeated febrile illnesses associated with various other symptoms .<br />
Except for PFAPA, the genetic basis <strong>of</strong> each <strong>of</strong> these diseases is<br />
known . Predominant mutations in MEFV, TNF1A and CARD15/NOD2<br />
were analyzed in 57 children diagnosed with PFAPA .<br />
Children with PFAPA were carefully selected based on clinical signs<br />
and symptoms . All patients were recruited at the Department <strong>of</strong> Pediatrics,<br />
Meyer Hospital <strong>of</strong> Children, Rambam-Health Care Campus during<br />
2006-2007 . Parents were invited to include their PFAPA diagnosed<br />
children in the study and to sign inform consent forms as customary .<br />
Clinical information was complemented during physicians-parents encounter<br />
and a blood sample was drawn for molecular testing . PCR and<br />
RFLPs for the predominant mutations in MEFV, TNF1A and CARD15/<br />
NOD2 genes were performed .<br />
The cohort consisted <strong>of</strong> 57 children with PFAPA [33 (58%) boys; 24<br />
(42%) girls] . The mean age at diagnosis was 30 .64±16 .4 months,<br />
boys were diagnosed earlier than girls (26 .18±13 .83 and 36 .41±18 .32<br />
months, respectively, p=0 .05) . Predominant mutations in the MEFV<br />
genes were found in 16 (28 .1%) children, mutations in TNF1A were<br />
found in 3 (5 .2%) children and mutations in CARD15 also in 3 (5 .2%)<br />
children . The clinical symptoms (e .g . pharangytis, aphthous stomatitis,<br />
abdominal pain and cervical adenitis) were equally manifested<br />
between carriers and non-carriers .<br />
In Israeli children diagnosed with PFAPA a higher frequency <strong>of</strong> mutations<br />
in MEFV gene were found compared to that observed in the<br />
general population .<br />
P01.345<br />
Analysis <strong>of</strong> the cAG repeat and A467t and W748s POLG<br />
mutations in iranian patients With multiple sclerosis<br />
H. Soltanzadeh 1 , M. Ataei 2 , M. Shaf 2 , M. Houshmand 2 , M. Nabavi 3 , K. Parivar 4 ,<br />
M. Ariany 5 , M. H. Sanati 2 ;<br />
1 Young researchers club. Science and Research <strong>of</strong> Islamic Azad University.<br />
National Institute for Genetic Engineering and Biotechnology, Tehran, Islamic<br />
Republic <strong>of</strong> Iran, 2 National Institute for Genetic Engineering and Biotechnology,<br />
Tehran, Islamic Republic <strong>of</strong> Iran, 3 Shahed university, Tehran, Islamic Republic<br />
<strong>of</strong> Iran, 4 Science and Research Islamic Azad University, Tehran, Islamic Republic<br />
<strong>of</strong> Iran, 5 Special Medical center, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
Multiple sclerosis (MS) is an autoimmune multifactorial disease that<br />
usually develops in susceptible young adults . A possible involvement<br />
<strong>of</strong> mitochondria in MS has been postulated because <strong>of</strong> a higher rate<br />
transmission <strong>of</strong> the disease from mother to child than from father to<br />
child . Also association between Leber’s Hereditary Optic Neuropathy<br />
a mitochondrial disease and MS is another evidence . Fatigue is a common<br />
problem <strong>of</strong> the MS patients which is relted to the energy production<br />
difficulty by the mitochondria. To investigate further the relationship<br />
between MS and mitochondria we analysed the gene encoding<br />
for polymerase G (POLG) . Among the nearly 50 disease mutations in<br />
the gene for the catalytic subunit <strong>of</strong> POLG, The A467T mutant enzyme<br />
possesses only 4% <strong>of</strong> wild-type DNA polymerase activity .<br />
Polymerase gene (pol G) is a two-subunit complex consisting <strong>of</strong> a<br />
140-kDa catalytic and a 55-kDa accessory subunit (p55the Nterminalcatalytic<br />
subunit contains a trinucleotide CAG repeat encoding a polyglutamine<br />
tract near the amino-terminus <strong>of</strong> the protein . Expansions<br />
<strong>of</strong> similar polyglutamine-encoding CAG microsatellite repeats in other<br />
genes are known to cause neurodegenerative disorders .<br />
Total genomic DNA was extracted from 60 idiopathic Ms Patients and<br />
40 controls . Primers were designed to amplify the 4 hot exones and<br />
CAG repeat length <strong>of</strong> the gene following by sequencing . The distribution<br />
<strong>of</strong> the POLG CAG repeat length in the control samples matched<br />
the distribution reported for control samples by others . The analysis<br />
<strong>of</strong> our sample shows no difference between the CAG repeat length<br />
distribution <strong>of</strong> control and ms disease samples analysis <strong>of</strong> exon 7, 8, 9,<br />
and13 <strong>of</strong> POLG gene from 60 DNA samples <strong>of</strong> MS patients showed no<br />
mutation . However this does not exclude the association <strong>of</strong> the gene<br />
in MS but it needs more investigation . Also it is necessary to test the<br />
other exones <strong>of</strong> the gene .<br />
P01.346<br />
TCF deletions in Pitt-Hopkins syndrome<br />
I. Giurgea1,2,3 , C. Missirian4 , S. Whalen1,2,3 , T. Fredriksen1,2,3 , T. Gaillon1,2,3 , J.<br />
Rankin5 , M. Mathieu-Dramard6 , G. Morin6 , D. Martin-Coignard7 , B. Chabrol8 ,<br />
J. Arfi9 , F. Giuliano10 , J. Lambert10 , L. Villard11 , N. Philip12,9 , M. Goossens1,2,3 , A.<br />
Moncla12,9 ;<br />
1INSERM U841, IMRB, département de génétique, Equipe 11, Créteil, France,<br />
2 3 Université Paris 12, Faculté de Médecine, IFR10, Créteil, France, AP-HP,<br />
Groupe Hospitalier Henri Mondor-Albert Chenevier, Service de biochimie et<br />
génétique, Créteil, France, 42Département de Génétique Médicale, Hôpital<br />
des enfants de la Timone, Marseille, France, 5Department <strong>of</strong> Clinical <strong>Genetics</strong>,<br />
Royal Devon and Exeter NHS Foundation Trust (Heavitree), Exeter, United Kingdom,<br />
6Département de Génétique Médicale, CHU d’Amiens - Nord, Amiens,<br />
France, 7Département de Génétique Médicale, CH du Mans, Le Mans, France,<br />
8Service de Neuropédiatrie, Hôpital des enfants de la Timone, Marseille, France,<br />
9Unité INSERM U491 « Génétique Médicale & Développement », Faculté<br />
de Médecine La Timone, Marseille, France, 10Service de Génétique, Hôpital<br />
L’Archet 2, Nice, France, 11Faculté de Médecine La Timone, Marseille, France,<br />
12Département de Génétique Médicale, Hôpital des enfants de la Timone, Marseille,<br />
France.<br />
Background: Pitt-Hopkins syndrome (PHS) is a syndromic mental retardation<br />
disorder marked by hyperventilation episodes and characteristic<br />
dysmorphism (large beaked nose, wide mouth, fleshy lips, and<br />
clubbed fingertips). PHS has been shown to be caused by de novo<br />
heterozygous mutations <strong>of</strong> the TCF4 gene, located in 18q21 . To expand<br />
the phenotypic spectrum <strong>of</strong> mutations and deletions <strong>of</strong> the TCF4<br />
gene, we studied 30 hitherto unexplored patients whose phenotype<br />
overlapped with PHS .<br />
Methods: The TCF4 gene was analysed by QMF-PCR, followed by<br />
sequencing . Large deletions were characterised by CGH array . All patients<br />
were karyotyped .<br />
Results: In three patients, 18q21 .1-q22 .2 deletions were revealed by